Page last updated: 2024-08-24

irinotecan and rucaparib

irinotecan has been researched along with rucaparib in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Augustine, T; Goel, S; Maitra, R; Nayak, J; Zhang, J	1

Other Studies

1 other study(ies) available for irinotecan and rucaparib

Article	Year
Sensitization of colorectal cancer to irinotecan therapy by PARP inhibitor rucaparib. Investigational new drugs, 2019, Volume: 37, Issue:5 Topics: Animals; Apoptosis; Cell Cycle; Cell Proliferation; Colorectal Neoplasms; Drug Resistance, Neoplasm; Drug Synergism; Drug Therapy, Combination; Humans; Indoles; Irinotecan; Mice; Mice, Nude; Poly(ADP-ribose) Polymerase Inhibitors; Topoisomerase I Inhibitors; Tumor Cells, Cultured; Xenograft Model Antitumor Assays	2019

Article

Year

Sensitization of colorectal cancer to irinotecan therapy by PARP inhibitor rucaparib.

Investigational new drugs, 2019, Volume: 37, Issue:5

Topics: Animals; Apoptosis; Cell Cycle; Cell Proliferation; Colorectal Neoplasms; Drug Resistance, Neoplasm; Drug Synergism; Drug Therapy, Combination; Humans; Indoles; Irinotecan; Mice; Mice, Nude; Poly(ADP-ribose) Polymerase Inhibitors; Topoisomerase I Inhibitors; Tumor Cells, Cultured; Xenograft Model Antitumor Assays

2019